Course of serological tests in treated subjects with chronic Trypanosoma cruzi infection: A systematic review and meta-analysis of individual participant data
- Sguassero, Yanina
- Roberts, Karen N.
- Harvey, Guillermina B.
- Comandé, Daniel
- Ciapponi, Agustín
- Cuesta, Cristina B.
- Aguiar, Camila
- Castro, Ana M. de
- Danesi, Emmaria
- Andrade, Ana L. de
- Lana, Marta de
- Escriba, Josep M.
- Fabbro, Diana L.
- Fernandes, Cloe D.
- Flores Chávez, María
- Hasslocher Moreno, Alejandro M.
- Jackson, Yves
- Lacunza, Carlos D.
- Machado-de-Assis, Girley F.
- Maldonado, Marisel
- Meirat, Wendell S. F.
- Molinau, Israel
- Monje Rumiw, María M.
- Muñoz San Martín, Catalina
- Murcia, Laura
- Castro, Cleudson Nery de
- Sánchez Negrette, Olga
- Segovia, Manuel
- Silveira, Celeste A. N.
- Solari Illescas, Aldo
- Steindel, Mario
- Streigerk, Mirtha L.
- Vera de Bilbao, Ninfa
- Zulantay Alfaro, Inés
- Sosa Estani, Sergio
DOIAbstract
Objective: To determine the course of serological tests in subjects with chronic Trypanosoma cruzi infection treated with anti-trypanosomal drugs. Methods: A systematic review and meta-analysis was conducted using individual participant data. Survival analysis and the Cox proportional hazards regression model with random effects to adjust for covariates were applied. The protocol was registered in the PROSPERO database (http://www.crd.york.ac.uk/PROSPERO; CRD42012002162). Results: A total of 27 studies (1296 subjects) conducted in eight countries were included. The risk of bias was low for all domains in 17 studies (63.0%). Nine hundred and thirteen subjects were assessed (149 seroreversion events, 83.7% censored data) for enzyme-li...
Add to ORKG